Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 250

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 250
---
 Splits); and (ii) the Company
may require each Buyer (or each Buyer may require the Company, as applicable) to participate in the sale of (a) one or more additional
convertible notes (which aggregate original principal amount for all additional convertible notes shall not exceed $9,500,000) (the “Additional
Notes”) and (b) related Warrants.

<div align='center'>II-1</div>

The Securities Purchase Agreement
is filed as Exhibit 4.1 of the Company’s current report on Form 6-K dated August 16, 2024 and is incorporated by reference herein.
The Initial Note is filed as Exhibit 10.25 of this registration statement.

Additionally, in connection
with the Securities Purchase Agreement, the Company entered into amendment and exchange agreements with certain holders of its convertible
promissory notes (the “Existing Notes” and each of such amendment and exchange agreements, an “Amendment and Exchange
Agreement”), pursuant to which the Company exchanged the Existing Notes by issuing, among other things, (i) senior convertible notes
in the aggregate principal amount of $2,700,000 (the “Exchange Notes”, and, together with the Initial Note and the Additional
Notes, the “Notes”) and (b) a series of warrants to initially acquire up to a certain number of Class A Ordinary Shares to
the holders of the Existing Notes set forth therein (the “Exchange Warrants” and the Series A Warrants and the Series B Warrants,
the “Warrants”). The Exchange Notes are in substantially similar form to the Initial Notes, which are discussed further below.

The Exchange Warrants expire
nine years after the issuance date and are initially exercisable for an aggregate of 3,253,012 Class A Ordinary Shares (without reflecting
any Reverse Stock Splits), subject to adjustment as provided therein. The Exchange Warrants may be exercised at any time after the exchange
date, subject to the Maximum Percentage (as defined in the Exchange Warrants). The initial exercise price of the Exchange Warrants is
$0.913 per share, subject to adjustment as provided therein. If at the time of exercise of the Exchange Warrants, there is no effective
registration statement registering our Class A Ordinary Shares underlying such warrants, such warrants may be exercised on a cashless
basis pursuant to their terms. The form of the Amendment and Exchange Agreement, the form of Exchange Notes, and the form of Exchange
Warrants are filed as Exhibits 4